Showing Results for
- Academic Journals (49)
Search Results
- 49
Academic Journals
- 49
- Search Terms:
- 1From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): F G Rücker [1]; S Sander [2]; K Döhner [1]; H Döhner [1]; J R Pollack [3]; L Bullinger [1] Myeloid leukemias are clonal disorders that are characterized by cytogenetic and molecular-genetic aberrations...
- 2From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): Y Hong [1]; G Wang [1]; A Gutierrez del Arroyo [1]; J Hernandez [1]; C Skene [1]; J D Erusalimsky [1, 2] Anagrelide (ANA) and hydroxycarbamide (HC) are two distinct pharmacological agents that inhibit bone...
- 3From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): J Bohnhorst [1]; T Rasmussen [2]; S H Moen [1]; M Fløttum [1]; L Knudsen [2]; M Børset [1]; T Espevik [1]; A Sundan [1] Multiple myeloma (MM) is an incurable B-cell malignancy characterized by accumulation...
- 4From: Leukemia. (Vol. 20, Issue 6) Peer-Reviewed
Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders.
Author(s): J-J Kiladjian [1]; N Elkassar [2]; B Cassinat [3]; G Hetet [4]; S Giraudier [5]; N Balitrand [3]; C Conejero [5]; J Briere [1]; P Fenaux [1]; C Chomienne [1]; B Grandchamp [4] Diagnosis of essential... - 5From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): M Trubia; F Albano; F Cavazzini; G R Cambrin; G Quarta; F Fabbiano; F Ciambelli; D Magro; J M Hernandez; M Mancini; D Diverio; P G Pelicci; F L Coco; C Mecucci; G Specchia; M Rocchi; V Liso; G Castoldi; A...
- 6From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): M Nakagawa [1, 2]; M Seto [1]; Y Hosokawa [1] Mucosa-associated lymphoid tissue lymphoma In 1983, Issacson and Wright[1] first observed that the histology of extranodal lymphomas was similar to that of...
- 7From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): C-D Klemke [1, 2]; B Fritzsching [1, 3]; B Franz [1]; E V Kleinmann [1]; N Oberle [1]; N Poenitz [2]; J Sykora [4]; A H Banham [5]; G Roncador [6]; A Kuhn [1, 7]; S Goerdt [2]; P H Krammer [1]; E Suri-Payer...
- 8From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): F E Nicolini [1]; S Corm [2, 3]; Q-H Lê [1]; N Sorel [4]; S Hayette [5]; D Bories [6]; T Leguay [7]; L Roy [8]; S Giraudier [6]; M Tulliez [6]; T Facon [2]; F-X Mahon [7]; J-M Cayuela [9]; P Rousselot [10]; M...
- 9From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): M-J P L Stevens-Kroef [1]; E F P M Schoenmakers [1]; M van Kraaij [2]; E Huys [1]; S Vermeulen [1]; B van der Reijden [2]; A Geurts van Kessel [1] Particular subtypes of acute myeloid leukemia (AML)s and...
- 10From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): A Hamilton [1]; L Elrick [1]; S Myssina [1]; M Copland [1]; H Jørgensen [1]; J V Melo [2]; T Holyoake [1] Chronic myeloid leukaemia (CML) is a clonal myeloproliferative disorder of haemopoietic stem cells,...
- 11From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): R Villuendas [1]; J L Steegmann [2]; M Pollán [3]; L Tracey [1]; A Granda [2]; E Fernández-Ruiz [4]; L F Casado [5]; J MartÃnez [6]; P MartÃnez [6]; L LombardÃa [7]; L Villalón [8]; J Odriozola [8]; M A...
- 12From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): J Bergeron [1]; E Clappier [2]; B Cauwelier [3]; N Dastugue [4]; C Millien [1]; E Delabesse [1]; K Beldjord [1]; F Speleman [3]; J Soulier [2]; E Macintyre [1]; V Asnafi [1] Recognized T-cell acute...
- 13From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): R La Starza [1]; A Aventin [2]; C Matteucci [1]; B Crescenzi [1]; S Romoli [1]; N Testoni [3]; V Pierini [1]; S Ciolli [4]; C Sambani [5]; A Locasciulli [6]; E Di Bona [7]; M Lafage-Pochitaloff [8]; M F...
- 14From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): Y Lu [1]; Y-B Xu [1]; T-T Yuan [2]; M-G Song [2]; M Lübbert [3]; M Fliegauf [3]; G-Q Chen [1, 2] The chromosome translocation (8;21) (q22;q22) is one of the most frequently occurred chromosomal...
- 15From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): G Xu [1]; R Kanezaki [1]; T Toki [1]; S Watanabe [1, 2]; Y Takahashi [1]; K Terui [1]; I Kitabayashi [3]; E Ito [1] Down syndrome (DS), which is caused by trisomy 21, is one of the most common human...
- 16From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): L Reiniger [1]; C Bödör [1]; à Bognár [1]; Z Balogh [1]; J Csomor [1]; à Szepesi [1]; L Kopper [1, 2]; A Matolcsy [1] Transformation of chronic lymphocytic leukemia (CLL) to a more aggressive lymphoma...
- 17From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): P Gorello [1]; G Cazzaniga [2]; F Alberti [3]; M G Dell'Oro [2]; E Gottardi [3]; G Specchia [4]; G Roti [1]; R Rosati [1]; M F Martelli [1]; D Diverio [5]; F Lo Coco [6]; A Biondi [2]; G Saglio [3]; C Mecucci...
- 18From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): S Poulain [1]; I Dervite [2]; X Leleu [3]; J Fernandes [4]; L Stalnikiewicz [2]; A-S Moreau [3]; V Coiteux [3]; S de Botton [3]; P Duthilleul [1]; P Morel [2] Autoimmune hemolytic anemia (AIHA) and...
- 19From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): M Bilban [1, 2]; D Heintel [3]; T Scharl [4]; T Woelfel [4]; M M Auer [2, 3]; E Porpaczy [3]; B Kainz [3]; A Kröber [5]; V J Carey [6]; M Shehata [2, 3]; C Zielinski [2]; W Pickl [7]; S Stilgenbauer [5]; A...
- 20From: Leukemia. (Vol. 20, Issue 6) Peer-ReviewedAuthor(s): R Mous [1]; P Savage [2, 3]; E B M Remmerswaal [4]; R A W van Lier [4]; E Eldering [4]; M H J van Oers [1] At present, there is no curative treatment for B-cell chronic lymphocytic leukaemia (B-CLL). The...